ER Targeted PET with 18F-Fluoroestradiol

ER Targeted PET with 18F-Fluoroestradiol (Cerianna):  Applications and Interpretation
Sponsored by the ACNM

Gary Ulaner, MD, PhD, FACNM; Katherine Zukotynski, BASc, MD, PhD, P.Eng; Twyla Bartel, DO, MBA, FACNM, FSNMMI

Ashwin Parihar, MBBS, MD       

Gary Ulaner, MD, PhD, FACNM

Hoag Family Cancer Institute

Course Summary
Fluoroestradiol (Cerianna) PET has been FDA approved for patients with breast cancer.  This webinar will review the clinical applications and interpretation of Fluoroestradiol PET.  The target audience will be  nuclear medicine physicians and radiologists.  The course would provide expertise in the proper application and interpretation of Fluoroestradiol PET for webinar attendees.  The expected outcomes are that attendees will better understand Fluoroestradiol PET and will be able to apply it more appropriately and effectively in their clinics.

Course Objectives

1. Understand the basic mechanism of Fluoroestradiol PET

2. Discuss appropriate clinical indications for Fluoroestradiol PET

3. Improve interpretation of Fluoroestradiol PET


CE Information
CE Credit applications for physicians, pharmacists, physicists and technologists are pending. Check back for updates regarding CE Credit status.

4/19/2022 12:00 PM - 1:00 PM
Eastern Daylight Time

Sign In